On today’s episode of Free Lunch, Associate Stock Strategist Ryan McQueeney covers the latest in the ongoing trade talks between the U.S. and China and highlights why trendy memory-chip maker Micron (MU - Free Report) moved higher this morning. Later, Ryan digs into two key charts from a pair of popular marijuana stocks.
Want more video content from Zacks? Subscribe to Zacks Investment News now!
Free Lunch is a brand new show from Zacks Investment Research. It will be streamed live, four times per week, and will feature breaking news and analysis from Zacks strategists. Free Lunch is available on YouTube, Facebook Live, Twitter, Ustream, and more.
Up first, Ryan discusses the news from Treasury Secretary Steve Mnuchin over the weekend that offsetting tariffs from the U.S. and China are being put on hold amid positive discussions between the two nations. This gave investors worried about a tit-for-tat trade war some relief this morning.
Meanwhile, trendy chip maker Micron moved higher in early Monday trading after raising its earnings and revenue guidance. Micron said it now expects Q3 revenue in the range of $7.70 billion to $7.80 billion, up from its previous guidance of $7.20 billion to $7.60 billion.
The firm also projected adjusted earnings of $3.12 to $3.16 per share, well above its previously-announced range of $2.76 to $2.90 per share (also read: Why Is Micron Stock Gaining Today?).
Finally, Ryan wraps things up by digging into two the charts from two key “marijuana stock” plays: GW Pharmaceuticals and Innovative Industrial Partners (IIPR - Free Report) . GWPH is a budding biotech looking to get approval for its cannabinoid-based treatments, while IIPR is a REIT focused on acquiring medical marijuana facilities.
Check out the show to hear more about the latest movements in these stocks, as well as what Ryan is looking for going forward!
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
On today’s episode of Free Lunch, Associate Stock Strategist Ryan McQueeney covers the latest in the ongoing trade talks between the U.S. and China and highlights why trendy memory-chip maker Micron (MU - Free Report) moved higher this morning. Later, Ryan digs into two key charts from a pair of popular marijuana stocks.
Want more video content from Zacks? Subscribe to Zacks Investment News now!
Free Lunch is a brand new show from Zacks Investment Research. It will be streamed live, four times per week, and will feature breaking news and analysis from Zacks strategists. Free Lunch is available on YouTube, Facebook Live, Twitter, Ustream, and more.
Up first, Ryan discusses the news from Treasury Secretary Steve Mnuchin over the weekend that offsetting tariffs from the U.S. and China are being put on hold amid positive discussions between the two nations. This gave investors worried about a tit-for-tat trade war some relief this morning.
Meanwhile, trendy chip maker Micron moved higher in early Monday trading after raising its earnings and revenue guidance. Micron said it now expects Q3 revenue in the range of $7.70 billion to $7.80 billion, up from its previous guidance of $7.20 billion to $7.60 billion.
The firm also projected adjusted earnings of $3.12 to $3.16 per share, well above its previously-announced range of $2.76 to $2.90 per share (also read: Why Is Micron Stock Gaining Today?).
Finally, Ryan wraps things up by digging into two the charts from two key “marijuana stock” plays: GW Pharmaceuticals and Innovative Industrial Partners (IIPR - Free Report) . GWPH is a budding biotech looking to get approval for its cannabinoid-based treatments, while IIPR is a REIT focused on acquiring medical marijuana facilities.
Check out the show to hear more about the latest movements in these stocks, as well as what Ryan is looking for going forward!
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on MU - FREE
Get the latest research report on IIPR - FREE